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Background: No information is available on the attitudes of General Practitioners (GPs) and Breast Surgeons (BSs) to their
delivery of genetic, environmental and lifestyle risk factor information about breast cancer. The aim of this study was to
describe the Breast Cancer Risk Communication Behaviours (RCBs) reported by GPs and BSs in four European countries
and to determine the relationships between their RCBs and their socio-occupational characteristics.
Methods: Self-administered questionnaires assessing breast cancer risk communication behaviours using vignettes were
mailed to a sample of Breast Surgeons (BS) and General Practitioners (GP) working in France, Germany, the Netherlands,
and the UK (N = 7292). Their responses to questions about the risk factors were first ordered and compared by specialty
and country after making multivariate adjustments. Rather than defining a standard Risk Presentation Format (RPF) a priori,
the various RPFs used by the respondents were analyzed using cluster analysis.
Results: Family history and hormonal replacement therapy were the risk factors most frequently mentioned by the 2094
respondents included in this study. Lifestyle BC risk factors such as obesity and alcohol were rarely/occasionally
mentioned, but this point differed (p < 0.001) depending on the country and the specialty of the providers involved. Five
distinct RPF profiles including the numerical/verbal presentation of absolute/relative risks were identified. The most
frequently encountered RPF (34.2%) was characterized by the fact that it included no negative framing of the risks, i.e., the
probability of not developing cancer was not mentioned. Age, specialty and country of practice were all found to be
significant determinants of the RPF clusters.
Conclusions: The increasing trend for GPs and BSs to discuss lifestyle risk factors with their patients suggests that this
may be a relevant means of improving breast cancer prevention. Physicians’ risk communication skills should be
improved during their initial and vocational training.
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Multiple risk factors contribute to the occurrence of
breast cancer. It has been clearly established by now that
lifetime exposure to genetic, environmental and lifestyle
risk factors play an important role in the aetiology of
this disease. Convincing or at least strong evidence has* Correspondence: claire.julian-reynier@inserm.fr
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unless otherwise stated.been presented showing that genetic mutations such as
BRCA1/BRCA2 or a family history of breast cancer, hormo-
nal factors increasing the duration of exposure to oestro-
gens such as early menarche/late menopause/hormonal
replacement therapy/oral contraceptives, exposure to ionis-
ing radiation at an early age (especially <30 years) and a
high breast density can all contribute to breast cancer [1-3].
Decreasing the duration of exposure to oestrogens by prac-
tising breast-feeding for at least 25 months has been found
to decrease the rates of occurrence of breast cancer [4].
Lifestyle risk factors such as a high alcohol consumptionentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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weight gain after 18 years of age), have been found to
contribute significantly to the occurrence of breast
cancer, whereas smoking is a risk factor on which more
evidence is required [1-3]. Interactions between these
factors have also been described, especially in BRCA1/2
mutation carriers [5].
As soon as the first genes predisposing their carriers
to hereditary breast/ovarian/colorectal cancer were iden-
tified, cancer genetic clinics were organised in many indus-
trialized countries to inform people at risk and their
families [6-11]. Since an increasingly large target popula-
tion is becoming eligible for cancer genetic counselling/
genetic testing, many primary care providers and General
Practitioners are now also being expected to deliver rele-
vant information to individuals at risk [12,13]. One of the
key issues which needs to be addressed by healthcare pro-
viders is how to communicate information about patients’
genetic/family risks and other significant changeable risk
factors for preventive purposes.
As far as we know, no information is available so far
about GPs’ and breast specialists’ attitudes to delivering
genetic, environmental and lifestyle risk factor informa-
tion about breast cancer. The state of the art and the
effectiveness of risk communication have been reviewed
extensively [14], especially in the context of genetic cancer
risks [15-17]. The “best” theoretical risk communication
standards have been reported to consist in presenting nu-
merical information with or without a verbal interpretation,
presenting both the absolute and relative risks, and discuss-
ing the positively and negatively framed event [14]. How-
ever, the authors of empirical studies on the pragmatic and
contextual aspects of risk communication have pointed out
that even personally tailored breast cancer risk information
may not account completely for the specific factors that pa-
tients hold to be the most relevant [18] and that the com-
plexity of the task of providing patients with medical
information obliges practitioners to make choices [19].
The aim of this study was first to ascertain how
General Practitioners (GPs) and Breast Surgeons (BSs)
practicing in several European countries regarded their
Breast Cancer Risk Communication Behaviours (RCBs),
and to determine the relationship between their RCBs
and their socio-occupational characteristics.
Methods
The InCRisC study
The International Cancer Risk Communication Study
(InCRisC study) was a multicentre European research
project designed to describe risk communication practices
and the management of familial breast cancer in primary
care. It was carried out in 2010 in four European countries
(France, Germany, the Netherlands and the UK). Data col-
lection was organised separately in each country by theco-authors involved in the project (CJR for France, JS and
IN for Germany, CJA and AT for the Netherlands, and
DGE and HH for UK). Questionnaires taking about
25 min to complete were posted to a sample of 3999 GPs
and a sample of 3293 breast surgeons in each of these four
countries. The international study methodology was
reviewed and approved by the German Federal Ministry of
Education and Research «Ethical, Legal and Social Impli-
cation of Biomedical Research Programme» which funded
the project. Each country was in line with its own national
regulation. The review procedure included the assessment
of ethical issues, informed consent, confidentiality and
regulation to data access. A detailed description of the
study design has been published elsewhere [20]. Practi-
tioners who were not consulted by any breast cancer pa-
tients during the year prior to the survey were excluded
from the analysis.
Questionnaire
The questionnaire included 70 questions based on a set
of clinical vignettes about women with a family history
of breast cancer and the initial steps in the BRCA1/2
genetic testing process. Here we present only the vari-
ables addressed in the questionnaire on the topic of risk
communication (Figure 1).
Communication about breast cancer risk factors
Practitioners were asked what risk information they pro-
vided during their consultations when unaffected women
with a family history of breast cancer consulted them
about their risk of developing breast cancer: risk assess-
ment based on the family history, increased risks due to
alcohol consumption, obesity, oral contraception, and/or
HRT, and risk prevention based on physical exercise,
child bearing at a younger age, and/or breast feeding.
Answers were given on a 6-item Likert scale (never;
very rarely; rarely; occasionally; frequently; always).
Scores ranging from 0 (never) to 5 (always) were com-
puted on each of these 8 variables. The questions used
are given in Figure 1-Q10.
Risk presentation formats
In the first scenario presented to the physicians (Figure 1-
Q11), they were asked how they would present the breast
cancer risks involved to their patients. Six different formats
were proposed: in the first four formats, absolute risks were
presented, while the last two corresponded to relative risks
and negative framing, respectively. Answers to these 6 for-
mats were given on a 4-item Likert scale (certainly; prob-
ably; probably not; certainly not); binary outcomes were
analysed, in which the responses certainly/probably were
compared with the other possible answers. The first three
types of presentation were then grouped together, as they
Q10 When an unaffected woman with a family history of breast cancer consults you about 
her risk of developing breast cancer which of the following information will you 
provide in the consultation?
Please tick one box per line
I will provide: Never Very 
rarely
Rarely Occasionally Frequently Always
Risk assessment based 
upon the family history
Information on increased 





Information on reduced 
breast cancer risk due to:
a) Physical exercise
b) Child bearing at a 
younger age
c) Breast feeding
The following are two different scenarios about breast cancer. We would like to know 
how you would manage these situations in your practice. 
Scenario 1:
Louise, an unaffected 35 year old woman, has a 32 year old sister who has recently been 
diagnosed with breast cancer. Louise wants to know about her own cancer risk.
(…)
Q11-3 We are interested in how health professionals present risk information to a patient. 
How would you present Louise’s risk to her? Please answer even if you have stated 
no in Q11-2.







You have a 20% chance of getting breast 
cancer in your lifetime.
Option B:
Among 100 women like you, 20 will get breast 
cancer in their lifetime.
Option C:
1 in 5 women like you, will get breast cancer 
in their lifetime.
Option D:
Your chance of getting breast cancer in your 
lifetime is moderate.
Option E:
Your chance of getting breast cancer is twice 
the general population chance of getting 
breast cancer.
Would you communicate the chance of not
developing breast cancer?
Figure 1 Questions adressed to doctors on risk communication –InCRisC study.
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absolute risks.
Socio-demographics and occupational characteristics
These characteristics included all the participants’ gen-
der, age, and number of years of practice. GPs were also
asked approximately how many patients consulted themper week, while specialists were asked about their speciality
and the number of newly diagnosed breast cancer patients
who had consulted them during the previous year.
Statistical analysis
Chi2 and Fisher’s exact tests were used in the univariate
comparisons on categorical data and Student’s t-tests on
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using analyses of variance (ANOVA) on quantitative
dependent variables. Logistic regressions were per-
formed in order to compare the physicians’ profiles
identified in the cluster analysis in terms of their risk
presentation formats. In the multivariate analyses, sys-
tematic adjustments were made for age, gender, coun-
try and specialty.
Rather than defining the formats used by physicians
a priori, we decided to identify their profiles statisti-
cally, based on their answers to the questions about
their risk presentation practices, using cluster analysis.
The advantage of this method was that the profiles
could be tested without making any a priori hypoth-
eses about them. The cluster analyses were performed
using the conventional agglomerative hierarchical pro-
cedure [21] to attribute individuals to clusters so that
those belonging to the same cluster were as similar
as possible and each cluster was clearly distinct from
the others. In this way, a set of contrasting profiles
reflecting the physicians’ various risk presentation
practices was set up. In order to avoid fixing the
number of clusters a priori, an automatic procedure
was used to select the best distributions (from 3–10)
using Ward’s method [22].
An overall score on the communication of risk fac-
tors other than family history and HRT was calculated
by summing together all the risk factor scores except
for family history. This score ranged from 0 to 30.
The Statistical Package for Social Science (SPSS/PC
released 18.0) was used to perform all the statistical ana-
lyses (SPSS Inc., Chicago, IL, USA).Table 1 Characteristics of the sample – InCRisC (N = 2094)
France G
GPs n = 269 n
Mean (SD) M
Age* 48.5 (9.2) 5
Number of years of medical practice* 21.9 (9.1) 2
n (%) n
Gender male* 170 (63.2) 2
Weekly number of consultations > 100* 144 (53.5) 4
Breast surgeons n = 168 n
Mean (SD) M
Age* 52.1 (10.1) 5
Number of years of medical practice* 25.8 (10.1) 2
n (%) n
Gender male* 147 (87.5) 2




The final sample analysed (N = 2094) consisted of 1189
GPs and 905 breast surgeons.
The response rates differed significantly from one
country to another (p < 0.001): 40.6% in France, 28.4% in
Germany, 38.6% in the Netherlands, and 30.1% in the
United Kingdom. Details of the response rates obtained
in these countries have been presented elsewhere [20].
Among the respondents, 7 GPs and 22 Breast Surgeons
were excluded from the analysis because they declared that
they had not been consulted by any breast cancer patients
during the previous year.Description of the sample
Doctors’ socio-occupational characteristics differed among
the four countries (Table 1).Informing patients about breast cancer risks
BS informed their patients more frequently than GPs
about all the risk factors except for oral contraception
and HRT, on which GPs obtained higher scores (Table 2).
Information about all the risk factors studied here was
communicated differently between countries, but the differ-
ences were much stronger in the case of risk factors other
than family history and HRT (Table 3). German practi-
tioners obtained the highest scores, whereas Dutch practi-
tioners had the lowest scores on risk factors other than
family history and HRT; French and British practitioners
obtained intermediate scores. HRT yielded higher scores
than the other risk factors in all the countries involved,ermany The Netherlands UK Total
= 449 n = 264 n = 207 n = 1189
ean (SD) Mean (SD) Mean (SD) Mean (SD)
4.2 (7.7) 49.5 (8.0) 45.1 (9.2) 50.3 (9.0)
5.0 (8.3) 20.1 (8.7) 16.5 (9.5) 21.7 (9.3)
(%) n (%) n (%) n (%)
95 (65.7) 175 (66.3) 85 (41.1) 725 (61.0)
11 (91.5) 171 (64.8) 131 (63.3) 857 (72.1)
= 458 n = 122 n = 157 n = 905
ean (SD) Mean (SD) Mean (SD) Mean (SD)
0.7 (7.4) 46.7 (8.9) 48.3 (8.7) 50.0 (8.6)
2.3 (7.9) 16.3 (7.9) 14.8 (8.9) 20.8 (9.5)
(%) n (%) n (%) n (%)
50 (54.6) 85 (69.7) 105 (66.9) 587 (64.9)
05 (22.9) 21 (17.2) 75 (47.8) 241 (26.6)
Table 2 Risk factors presented to patients, depending on practitioners’ (GPs’ and Breast Surgeons’) speciality InCRisC
(N=2094)
GP (n=1189) BS (n=905)
Mean score ± SD Rank Mean score ± SD Rank p-value*
Family history of BC 3.4 ± 1.5 2 4.1 ± 1.2 1 <.001
HRT 3.9 ± 1.1 1 3.8 ± 1.3 2 0.029
Oral contraception 3.2 ± 1.5 3 2.6 ± 1.7 8 <.001
Breast feeding 2.8 ± 1.6 4 3.1 ± 1.5 5 <.001
Physical exercise 2.6 ± 1.7 5 3.3 ± 1.7 3 <.001
Obesity 2.5 ± 1.6 6 3.2 ± 1.6 4 <.001
Childbearing at a younger age 2.2 ± 1.6 8 2.7 ± 1.6 7 <.001
Alcohol 2.3 ± 1.7 7 2.8 ± 1.7 6 <.001
Risk factors for BC other than family history and HRT (sum) 15.5 ± 7.8 17.7 ± 7.5 <.001
BC: Breast Cancer/BS: Breast Surgeon/HRT: Hormonal Replacement Therapy.
*Adjusted for age, gender and country using multifactor ANOVAs.
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all the countries except for Germany.Preferred risk presentation formats (RPF)
In order to analyze this point, we opted for a five-cluster
approach, which seemed to be the most relevant from
both the statistical and clinical points of view (Table 4).
The first cluster included 17.6% of the respondents.
These respondents reported that they presented the risks
in absolute numerical terms and in a negatively framed
way, without any verbal description of the absolute risk
and without mentioning the relative risks. This cluster
was labelled “No verbal formulation & No relative risks
mentioned”.
The second profile (34.2%) was that which occurred
most frequently. It was characterized by the presentation
of fairly heterogeneous information, and especially by
the fact that only 2.9% stated that they would presentTable 3 Risk factors presented by the practitioners (GPs and Bre
(N=2094)
France (n=437) Germa
Mean ± SD Rank Mean
Family history of BC 3.8 ± 1.3 1 3.7 ± 1
HRT 3.8 ± 1.3 1 3.9 ± 1
Oral contraception 2.8 ± 1.7 3 2.8 ± 1
Breast feeding 2.8 ± 1.7 3 3.3 ± 1
Obesity 2.5 ± 1.7 5 3.4 ± 1
Physical exercise 2.5 ± 1.8 5 3.8 ± 1
Child bearing at a younger age 2.3 ± 1.7 7 2.8 ± 1
Alcohol 2.2 ± 1.8 8 3.1 ± 1
Risk factors for BC other than family history
and HRT (sum)
15.0 ± 8.3 19.0 ±
BC: Breast Cancer/HRT: Hormonal Replacement Therapy.
*Adjusted for age, gender and specialty using multifactor ANOVAs.negatively framed risks, i.e., the probability of not devel-
oping cancer. This cluster/profile was labelled “No nega-
tive framing”.
The third profile (12.7%) included practitioners who
always presented the absolute numerical risks, the relative
risks, and negatively framed risks. None of them described
the absolute risks verbally. This group was labelled “No
verbal formulation”.
In the fourth group (18.0%), the absolute risks were
presented both numerically and verbally, and the risks
were negatively framed. Nearly half of the members of
this group also presented the relative risks. They were
labelled as “Risks presented in all 4 ways”.
The last cluster (17.5%) included doctors who did not
present the risks in absolute numerical terms and always
framed them negatively. Most of this group presented
the absolute risks verbally as well as presenting the rela-
tive risks. It was labelled “Absolute numerical risks not
presented”.ast Surgeons), depending on the country of origin – InCRisC
ny (n=907) NTL (n=386) UK (n=364)
± SD Rank Mean ± SD Rank Mean ± SD Rank p-value*
.5 2 3.5 ± 1.4 2 3.7 ± 1.4 2 0.023
.2 1 3.7 ± 1.2 1 3.9 ± 1.0 1 0.002
.7 7 2.9 ± 1.5 3 3.3 ± 1.4 3 <.001
.5 5 2.3 ± 1.5 4 2.9 ± 1.5 4 <.001
.5 4 1.8 ± 1.5 5 2.8 ± 1.5 5 <.001
.4 3 1.6 ± 1.5 7 2.3 ± 1.6 8 <.001
.6 7 1.8 ± 1.5 5 2.5 ± 1.5 6 <.001
.6 6 1.6 ± 1.5 7 2.5 ± 1.6 6 <.001
8.1 12.0 ± 7.0 16.3 ± 7.4 <.001
Table 4 Clusters based on the risk information presented to patients – InCRisC (N=2094)










n (%) n (%) n (%) n (%)
Cluster 1: “No Verbal formulation & no Relative Risk
mentioned” (n=368)
368 (100.0) 0 (0.0) 0 (0.0) 368 (100.0)
Cluster 2: “No negative framing” (n=717) 479 (66.8) 249 (34.7) 280 (39.1) 21 (2.9)
Cluster 3: “No Verbal Formulation” (n=267) 267 (100.0) 0 (0.0) 267 (100.0) 267 (100.0)
Cluster 4: “Risks presented in all 4 ways” (n=376) 376 (100.0) 376 (100.0) 157 (41.8) 376 (100.0)
Cluster 5: “Absolute numerical risks not presented”
(n=366)
0 (0.0) 268 (73.2) 212 (57.9) 366 (100.0)
GPs (n=1189) 830 (69.8) 475 (39.9) 463 (38.9) 743 (62.5)
BS (n=905) 660 (72.9) 418 (46.2) 453 (50.0) 655 (72.4)
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The fourth cluster “Risks presented in all 4 ways”, which
was taken to be one of the “best standards” for presenting
risk information, was compared with each of the other
clusters (Table 5).
In comparison with cluster 4, the respondents in cluster
1 “No verbal formulation & No relative risks mentioned”
were more frequently GPs and belonged to a younger age-
group, and were less frequently from the NTL.
In comparison with cluster 4, cluster 2 “No negative
framing” contained a higher proportion of GPs and a higher
proportion of French doctors.
In comparison with cluster 4, cluster 3 “No verbal for-
mulation” included younger practitioners and a higher
proportion of French doctors.
In comparison with cluster 4, cluster 5 “Absolute
numerical risks not presented” more frequently included
GPs and doctors practicing outside the UK.
To summarize, GPs were more frequently allotted to
clusters corresponding to “incomplete” risk presentation
formats; and the clusters brought to light some of the speci-
ficities of the countries under investigation (the NTL vs the
others, France vs the others, UK vs the others). Although a
younger age was associated with less verbal communication
about the risks, gender was not found to be a significant de-
terminant of the respondents’ risk communication profiles.
Discussion and conclusion
This international survey is the first to assess how European
GPs and specialised practitioners caring for healthy women
under breast cancer surveillance regard their responsibility
for assessing and communicating genetic, environmental
and lifestyle breast cancer risk factors to their patients.
First, the majority of these European practitioners re-
ported that they frequently assessed family history and
hormonal replacement therapy (HRT) but only occasion-
ally discussed patients’ lifestyle BC risk factors such asobesity, physical exercise and alcohol (Table 2). Breast sur-
geons communicated more frequently than GPs with their
patients about all the breast cancer risk factors studied,
except for HRT and oral contraception. Health providers
from the Netherlands communicated much less frequently
about patients’ lifestyle BC risk factors than those from the
other countries, especially Germany, whereas French and
UK doctors gave intermediate responses to this question.
The relatively similar attitudes to discussing patients’
family history and HRT risks observed in the various
countries may have been due to the large body of
research results published during the last fifteen years
on the assessment of breast cancer genetic risks [7,12]
and the deleterious effects of hormonal replacement
therapy [23]. This knowledge has now been quite widely
applied in the clinical practices of these practitioners,
who seem to be convinced of their relevance as the
result of either their initial/vocational training, the
guidelines published or peer group recommendations.
This was not found to be the case as far as lifestyle and
changeable risk factors such as obesity, physical exercise
and alcohol consumption are concerned. The import-
ance of these factors has only been recognized quite
recently, based on a lower level of evidence than with
risk factors which have been studied in the framework of
genetic testing and cancer genetic referrals, or HRT pre-
scription in the context of menopausal symptoms. In
addition, these factors are sometimes not even men-
tioned in the national guidelines for GPs and BSs. In
view of the increasing evidence available that obesity,
lack of physical exercise and probably high alcohol
consumption rates contribute to breast cancer, there is
certainly room for improvement in the guidelines
published and physicians’ lifestyle recommendations to
patients [24].
Secondly, the majority of the sample (more than
two thirds) declared that they expressed the absolute
Table 5 Description of clusters in terms of physicians’ characteristics – InCRisC (N=2094)
Cluster 1, n=368 (17.6%) Cluster 2, n=717 (34.2%) Cluster 3, n=267 (12.7%) Cluster 4, n=376 (18.0%) Cluster 5, n=366 (17.5%)
Mean (SD) AOR [CI 95%] p Mean (SD) AOR [CI 95%] p Mean (SD) AOR [CI 95%] p Mean (SD) AOR Mean (SD) AOR [CI 95%] p
Age 48.9 (9.1) 0.97 [0.96;0.99] 0.006 50.3 (8.9) 0.99 [0.98;1.01] 0.377 48.9 (8.4) 0.97 [0.96;0.99] 0.011 50.9 (8.7) 1 51.2 (8.5) 0.99 [0.98;1.01] 0.585
n (%) n (%) n (%) n (%) n (%)
Gender
Female 156 (19.9) 1 258 (33.0) 1 88 (11.3) 1 133 (17.0) 1 147 (18.8) 1
Male 212 (16.2) 0.91 [0.66;1.25] 0.564 459 (35.0) 0.98 [0.74;1.30] 0.886 179 (13.6) 1.18 [0.82;1.69] 0.374 243 (18.5) 1 219 (16.7) 0.81 [0.59;1.12] 0.207
Country
France 62 (14.2) 1 186 (42.6) 1 71 (16.2) 1 55 (12.6) 1 63 (14.4) 1
Germany 165 (18.2) 0.95 [0.62;1.46] 0.817 266 (29.3) 0.49 [0.34;0.70] <.001 81 (8.9) 0.38 [0.24;0.59] <.001 174 (19.2) 1 221 (23.4) 1.14 [0.75;1.73] 0.551
NL 48 (12.4) 0.53 [0.31;0.89] 0.016 144 (37.3) 0.54 [0.35;0.81] 0.003 63 (16.3) 0.65 [0.40;1.05] 0.081 74 (19.2) 1 57 (14.8) 0.63 [0.38;1.05] 0.076
UK 93 (25.5) 1.04 [0.64;1.70] 0.859 121 (33.2) 0.49 [0.32;0.75] 0.001 52 (14.3) 0.52 [0.31;0.86] 0.011 73 (20.1) 1 25 (6.9) 0.29 [0.16;0.51] <.001
Speciality
BS 144 (15.9) 1 258 (28.5) 1 147 (16.2) 1 195 (21.5) 1 161 (17.8) 1
GPs 224 (18.8) 1.76 [1.31;2.38] <.001 459 (38.6) 1.86 [1.44;2.41] <.001 120 (10.1) 0.82 [0.59;1.13] 0.225 181 (15.2) 1 205 (17.2) 1.47 [1.09;1.98] 0.011
Cluster 1: “No Verbal formulation & no Relative Risk mentioned” (n=368).
Cluster 2: “No negative framing” (n=717).
Cluster 3: “No Verbal Formulation” (n=267).
Cluster 4: “Risks presented in all 4 ways” (n=376).
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presenting them to patients (Table 4). Risks and rela-
tive risks were described verbally by only a minority
of the respondents (less than 44%). The five profiles
identified, corresponding to the preferred risk presen-
tation formats (RPFs), differed in several respects:
those of the relative majority of the respondents were
incomplete, since they omitted to frame the cancer
risks negatively, i.e., they did not mention the prob-
ability of not developing cancer (Cluster 2). Cluster 2
included more than one third of the sample and con-
sisted more frequently of GPs and French practitioners,
who expressed the opinion that they were responsible for
explaining the risks as part of primary prevention and can-
cer screening efforts, but that they could not be expected to
present a comprehensive picture of the risks. It has been
recommended that healthcare providers should focus on
the most relevant risks [14,15,19], and the respondents in
cluster 2 obviously thought it was not relevant to talk about
the chances of not developing cancer. This attitude might
be judged to be inacceptable, since it is known to bias
patients’ decision-making, which is contrary to the principle
of patients’ freedom of choice and their right to express
their own preferences. Cluster 4, “Risks presented in all 4
ways” along with cluster 3, “No verbal formulation”, which
can be said to adhere most closely to the ‘best standards’
defined in the literature [14,15], differed in that cluster 3
more frequently consisted of younger doctors practicing in
countries other than Germany/the UK. The “No verbal
formulation & No relative risks mentioned” group could be
said to consist of practitioners wanting to inform their
patients quickly and simply about the risks, avoiding the
difficult problem of explaining the relative risks, which has
been found to help patients decide between the options
available [19], but can be hard for patients to understand
[15], as well as the rather delicate problem of presenting
the risks verbally. On the other hand, risk presenters in the
“Absolute numerical risks not presented” group could be
said to show a more paternalistic attitude: making patients’
cancer risk perception as low as possible by presenting the
absolute risk figures and emphasizing the probability of not
developing the disease. These practitioners were more fre-
quently GPs working in countries other than the UK. This
paternalistic attitude is known to increase with age [25],
and has often been observed mainly in male doctors [25].
This was not found to be the case here. The reason
why the attitudes of the doctors surveyed here, as
reflected in their risk presentation formats, were so
variable may be that many of them had undergone
very little formal training in the basic principles of risk
communication [16] and that it is very difficult to
apply theoretical recommendations in a real life con-
text [19,26,27] in terms which can be easily under-
stood by the patients [18,28].This study has several limitations. First, it is about
self-reported risk communication practices, which may
differ from physicians’ actual practices. These declared
practices are likely to be a combination between what
the doctors said they would do and what they thought
they ought to do. In addition, the vignettes used here
provided only a short description of the complex clinical
context. The results should be interpreted accordingly.
Secondly, the questionnaire used in this study was
mailed to the doctors eligible to participate, and the re-
sponse rate obtained was low despite the reminders made
by mail and telephone. The low response rate certainly
reduce the possibility of generalizing the results obtained
by taking them to be representative of doctors’ risk com-
munication attitudes in a given country. Any country-
specific differences will have to be investigated further.
Although the response rate was low, it was comparable to
that obtained in other surveys of this kind [29]. However,
this survey is one of the few sources of information about
an international sample of GPs’ and BSs’ self-reported can-
cer risk communication practices. It is of particular interest
to note the different response rates obtained from one spe-
ciality and one country to another, since a low response
rate can also be taken to reflect a low level of interest in
the topic under investigation. It has been suggested that
the most interested doctors are more likely to answer ques-
tionnaires and are therefore likely to be over-represented
in the study sample.
The occupational characteristics of the practitioners
working in various countries’ healthcare systems have to
be taken into account when interpreting the data col-
lected. The role of the “GP gatekeeper” in the UK’s and
Netherlands’ healthcare systems differs from what oc-
curs in France and Germany, especially as regards refer-
rals, prescriptions and the existence of highly specialized
secondary and tertiary care centres. For example, mam-
mographic screening of healthy women at risk is performed
in the UK by breast surgeons, whereas this activity is mostly
carried out in France by Gynaeco-Obstetricians, who form
a very heterogeneous group of practitioners, some of whom
are medical gynaecologists (who do not carry out surgical
interventions and deal very little with breast cancer
patients), while others are involved only in obstetric care or
specialize in breast surgery.
Thedifferencesbetweenthebreastcancerriskcommunica-
tion profiles observed among non-geneticist healthcare pro-
viders inthese fourEuropeancountriesreflect thespecificities
oftherespectivehealthcaresystems,andespeciallythecontent
ofmedical training programs and guidelines. Risk communi-
cation skills should be part of a core communication curricu-
lum intended not only for geneticists/cancer geneticists and
genetic counsellors, but also for primary care providers [30].
Qualitativestudiesmighthelptounderstandwhypractitioners
adopt specific communication practices. The need for risk
Julian-Reynier et al. BMC Cancer  (2015) 15:243 Page 9 of 9communication skills has been underestimated in healthcare
providers’ initial and vocational training programs. In view of
the current trend to investigate all the possible actionable
scientific, medical and social risk factors involved in breast
cancer,thistopicwouldbeworthinvestigatingmoreclosely.
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